Compare InMode Ltd (INMD) vs Kenvue Inc. Common Stock (KVUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs Kenvue Inc. Common Stock — how do they compare? InMode Ltd trades at $14.2 (market cap $809.93M), while Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 42.1× InMode Ltd's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.
| INMD | KVUE | |
|---|---|---|
Market Cap | $809.93M | $34.06B |
Volume | 365,490 | 23,267,228 |
Sector | Health | Consumer Staples |
52-Week High | $16.62 | $19.83 |
52-Week Low | $12.76 | $14.11 |
Typical Hold Time | 28 Days | — |
Enterprise Value | $313.27M | $41.56B |
Dividend Yield | — | 4.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.20, up 1.36% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with 76.52% gross margins and 20.69% net income margin, though Q1 2026 earnings missed expectations. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share. Analyst consensus is divided with 45% buy ratings amid ongoing shareholder activism concerns.
The stock presents value opportunity with attractive valuation multiples (P/E 11.63, EV/EBITDA 4.48) but faces near-term execution risks. Key catalysts include Q3 earnings delivery and resolution of acquisition talks, while risks involve management credibility and competitive pressures in aesthetic medicine markets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →
